# LANTHANUM CARBONATE
> **ANDA206868** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2022-01-24
## Drug
- **FDA Application Number:** ANDA206868
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LANTHANUM CARBONATE
- **Generic name:** LANTHANUM CARBONATE
- **Active ingredients:** LANTHANUM CARBONATE
- **Dosage form:** TABLET, CHEWABLE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2022-01-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206868)
---
*MORVS · CC0 1.0*